E-Z-EM buys into virtual colonoscopy firm
This article was originally published in Clinica
E-Z-EM, claimed to be the world's largest manufacturer of contrast agents for gastrointestinal radiology, has taken around 5% of the equity in privately-owned PointDx, whose software visualises the colon using CT imaging and 3D computer-aided reconstruction. In addition, E-Z-EM has a three-year option to acquire a further 120,000 shares and get a seat on the board.
You may also be interested in...
Organizations like BARDA, CEPI and others are looking to partner with industry to rapidly test, manufacture, package and deploy vaccines and therapeutics, identifying areas they want to work together during BIO’s recent summit.
The economic stress on payers caused by the pandemic will cause a setback in the development of payment approaches for regenerative therapy, Blue Cross Blue Shield executive warns.
An interim final rule posted by the CMS this week widens further a series of telehealth exemptions and lab specimen collection payment provisions it has previously issued to help providers during the COVID-19 pandemic.